Company Search:
Advanced Search
Sponsored Links
Oasmia Pharmaceutical AB Company Snapshot
Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other companies in this sector in SWEDEN : Enzymatica AB (publ) (2020 sales of 111.25 million Swedish Kronor [US$13.19 million] of which 100% was Medical Devices), Camurus AB (336.00 million Swedish Kronor [US$39.83 million] of which 96% was Sales of development related goods and s), and Swedencare AB (publ) (240.30 million Swedish Kronor [US$28.48 million] of which 54% was PRODEN PLAQUEOFF).

Sales Analysis. Sales increased substantially in 2020: Oasmia Pharmaceutical AB reported sales of SEK 201.84 million (US$23.93 million) for the fiscal year ending April of 2020. This represents an increase of 10,094.1% versus 2019, when the company's sales were SEK 1.98 million. Sales of Licensing Revenues saw an increase that was more than double the company's growth rate: sales were up 48,207.4% in 2020, from SEK 417,000.00 to SEK 201.44 million. Not all segments of Oasmia Pharmaceutical AB experienced an increase in sales in 2020: sales of Sales of Goods fell 99.8% to SEK 2,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oasmia Pharmaceutical AB
  Stock Performance Chart for Oasmia Pharmaceutical AB
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 3.46
(Figures in Swedish Kronor)
1 Week -9.5%   13 Weeks 0.7%  
4 Weeks -14.4%   52 Weeks -57.2%  
Oasmia Pharmaceutical AB Key Data:
  Ticker: OASM Country: Sweden
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 201,843,000
(Year Ending Jan 2021).
Employees: 63
  Currency: Swedish Kronor Market Cap: 1,549,566,720
  Fiscal Yr Ends: April Shares Outstanding: 448,370,000
  Share Type: Closely Held Shares: 170,035,271
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.